United Kingdom · Question · Written question
UIN 166221
Voluntary Scheme for Branded Medicines Pricing and Access
Introduced
15 March 2023
Last action
30 March 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 March 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to the consultation outcome on Proposed update to the 2023 statutory scheme to control the costs of branded health service medicines, what steps he taking to help secure an agreement
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 March 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to the consultation outcome on Proposed update to the 2023 statutory scheme to control the costs of branded health service medicines, what steps he taking to help secure an agreement
Source: Commons
30 March 2023
Answer
The recent update to the statutory scheme will ensure the continued affordability of the National Health Service medicines budget and will maintain the longstanding policy of broad commercial equivalence between the statutory scheme and the voluntary sche...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-03-15/166221
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1604354
- uk · wq-1604354 · source updated 30 March 2023